AnthroTronix CEO to Conduct Davos Brain Challenge and Discuss Technology and the Brain at the Annual Meeting of the New Champions

WHO:   AnthroTronix (@AnthroTronix), a leader in digital health technology and engineering research and development committed to optimizing the interaction between people and technology. WHAT: At the World Economic Forum’s Annual Meeting of the New Champions, AnthroTronix CEO Dr. Cori Lathan (@clathan) will conduct the Davos Brain Challenge using its FDA-cleared DANA brain health assessment app. AnthroTronix held a similar exhibit at the World Economic Forum Annual Meeting in Davos-Klosters, Switzerland, earlier this year. AnthroTronix will invite attendees to assess their brain health and discover how innovative digital capabilities are transforming the way we assess and monitor our brain health. In addition, Dr. Lathan will discuss how digital technology, such as DANA, is improving our understanding of the brain and how we identify conditions and changes in cognitive function. Dr. Lathan has been named a Technology Pioneer and Young Global Leader by the World Economic Forum and is currently chair of their Global Agenda Council on Artificial Intelligence (AI) and Robotics. WHERE: Davos Brain Challenge Brain Hub, Works in Progress Exhibition Meijiang Convention & Exhibition Centre Tianjin, People’s Republic of China WHEN: June 26 – 28, 2016 Download PDF of press...

AnthroTronix and Cambridge Cognition have signed a distribution agreement to sell DANA, AnthroTronix’s FDA-cleared mobile brain health assessment app, to markets in the U.S. and Europe.

AnthroTronix and Cambridge Cognition Announce Distribution Agreement for Mobile Medical App Silver Spring, Md. – AnthroTronix and Cambridge Cognition Holdings PLC (Cambridge, UK – LSE: COG), have signed a distribution agreement to sell DANATM, AnthroTronix’s FDA-cleared mobile brain health assessment app, to markets in the U.S. and Europe. In the U.S., Cambridge Cognition will distribute DANA for use in academic research, clinical trials, and pharmaceutical development. In the United Kingdom and portions of Europe, DANA will be marketed for use in militaries, academic research, clinical trials, pharmaceutical development, and occupational health screenings. DANA, which was initially developed for use by the U.S. military to help evaluate the medical status of deployed service members, is a mobile medical app that administers game-like tests to assess a person’s brain/cognitive health within minutes. The app can help track cognitive function over time and during treatment for such conditions as depression, dementia/Alzheimer’s Disease, and Post-Traumatic Stress Disorder. DANA can be used on a phone or tablet and works on both the Android and iOS operating systems. “Brain health assessment is a fundamental part of an integrated approach to health care,” said Dr. Cori Lathan, @clathan, founder and CEO of AnthroTronix. “With this agreement, DANA has expanded its global reach and further establishes AnthroTronix as a leader in the growing brain and cognitive health assessment and training market, which is expected to surpass $6 billion worldwide by 2020.” “Having worked informally with AnthroTronix since 2015 we are confident that DANA fits within our existing point-of-care product portfolio and are excited by the opportunity to commercialize the product through established Cambridge Cognition sales channels to...